| Azilva (azilsartan) / Takeda |
ChiCTR2300073602: Study on the effect and transformation of Azilsartan on improving microcirculation in hypertension |
|
|
| Not yet recruiting | 4 | 60 | | Daily oral administration of Azilsartan tablets 20mg ;lifestyle intervention | The First Affiliated Hospital of Sun Yat-sen University; The First Affiliated Hospital of Sun Yat-sen University, Suzhou Industrial Park Xinxin Cardiovascular Health Foundation | Hypertension | | | | |
ChiCTR2300069585: The use of Azilsartan in patients with post-operation of radiofrequency ablation in AF |
|
|
| Not yet recruiting | 4 | 240 | | Oral Azilsartan ;Oral Candestan ;N/A | Shanxi Provincial Hospital of Cardiovascular Diseases; Shanxi Provincial Hospital of Cardiovascular Diseases, Constant Heart Hypertension / Cardiorenal Protection Medical Research Foundation | Atrial fibrillation | | | | |
ChiCTR2300071431: Study on the efficacy and mechanism of ARB drugs in patients with coronary microcirculation disorders after PCI surgery for coronary heart disease |
|
|
| Not yet recruiting | 4 | 120 | | Conventional drug therapy + Azilsartan 20mg qd ;Conventional drug therapy | Shaanxi Provincial People’s Hospital; Shaanxi Provincial People’s Hospital, Self-raised | Coronary heart disease PCI surgery with coronary microcirculation disorders | | | | |
ChiCTR2300071464: An observational study of a new generation of ARB drug, azilsartan, in elderly patients with hypertension and sarcopenia |
|
|
| Not yet recruiting | 4 | 150 | | Azisartan 20mg qd ;Azisartan 20mg qd | Sir Run Run Hospital, Nanjing Medical University; Sir Run Run Hospital, Nanjing Medical University, Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Hypertension | | | | |
AZAF, NCT05841654: Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension |
|
|
| Not yet recruiting | 4 | 400 | RoW | Azilsartan or antihypertensive drugs other than ACEI, ARB or ARNI | Beijing Tsinghua Chang Gung Hospital | Hypertension, Atrial Fibrillation | 06/25 | 10/25 | | |
ChiCTR2300076082: A single-center randomized crossover controlled trial to evaluate the efficacy and safety of azisartan in the treatment of proteinuria and renal function in non-dialytic hypertensive patients with IgA nephropathy |
|
|
| Not yet recruiting | 4 | 302 | | The first 12 weeks after taking azilsartan to valsartan; After taking valsartan in the first 12 weeks, it was changed to azilsartan. | Chinese Cardiovascular Association-HX Fund; Department of Nephrology, The Third Affiliated hospital of Southern Medical university, Guangzhou, China., Chinese Cardiovascular Association-HX Fund | IgA nephropathy | | | | |
ChiCTR2300073598: Comparison of the effects of sacubitril/valsartan and azilsartan on left ventricular remodeling in hypertensive patients with elevated angiopoietin-like 7 based on two-dimensional speckle-tracking echocardiography |
|
|
| Not yet recruiting | 4 | 60 | | Shakubaqu valsartan 200mg/dose, once daily; Azilsartan 20mg/dose, once daily | The First People's Hospital of Lianyungang; The First People's Hospital of Lianyungang, The Lianyungang Health Commission and The First People's Hospital of Lianyungang | hypertension | | | | |
NCT04668157: A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure |
|
|
| Completed | 3 | 9 | Japan | TAK-536 | Takeda | Hypertension | 12/23 | 12/23 | | |
| Not yet recruiting | 1 | 36 | | Taking single 20mg firstly, then taking single 40mg, finally taking multiple 40mg ;Taking single 40mg firstly, then taking single 20mg, finally taking multiple 40mg ;Taking single 40mg in the fast state firstly, then taking single 40mg in the fed state | The first affiliated hospital, School of Medicine, Zhejiang University; None, Jiangsu Hengrui Pharmaceutical Company | Hypertension | | | | |
ChiCTR2300073616: Efficacy and safety of azilsartan in mild-to-moderate non-dipper essential hypertension: a randomized controlled open-label study |
|
|
| Recruiting | 1 | 178 | | azilsartan treatment; Valsartan treatment | Qilu Hospital of Shandong University; Qilu Hospital of Shandong University, Qilu hospital | hypertension | | | | |
NCT04743063: Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty |
|
|
| Active, not recruiting | N/A | 40000 | US | sacubitril/valsartan, Angiotensin II Receptor Blockers, azilsartan, candesartan, eprosartan, Irbesartan, losartan, Olmesartan, telmisartan, valsartan | Brigham and Women's Hospital | Heart Failure, Systolic, Frailty | 12/22 | 12/22 | | |
ChiCTR2300069431: Efficacy and Safety of Azilsartan plus Tripterygium and its Extracts for Hypertensive Nephropathy |
|
|
| Not yet recruiting | N/A | 192 | | Azilsartan + Placebo ;Azilsartan Plus Tripterygium and its extracts ;Irbesartan + Placebo | The Eighth Affiliated Hospital, Sun Yat-Sen University (Shenzhen Futian); The Eighth Affiliated Hospital, Sun Yat-Sen University (Shenzhen Futian), The Department of Cardiology, the Eighth Affiliated Hospital, Sun Yat-Sen University | Hypertensive Nephropathy | | | | |
NCT05107960: A Study of Azilsartan in Children from 6 to Less Than 16 Years Old with High Blood Pressure |
|
|
| Completed | N/A | 5 | Japan | Azilsartan (TAK-536), AZILVA Tablets, AZILVA Granules 1% | Takeda | Hypertension | 08/24 | 08/24 | | |
NCT05753696: Azilsartan in Patients With Diabetic Kidney Disease and Hypertension |
|
|
| Recruiting | N/A | 106 | RoW | Azilsartan, Losartan | Second Affiliated Hospital, School of Medicine, Zhejiang University | Proteinuria, Kidney Dysfunction, Blood Pressure, Diabetic Kidney Disease | 10/24 | 12/24 | | |
ChiCTR2300073557: Study on the effect of azilsartan on the early index of renal injury |
|
|
| Not yet recruiting | N/A | 900 | | Azithartan 20mg/d; Valsartan 80mg/d | Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Hengxin Funding | Hypertensive nephropathy | | | | |
ChiCTR2300070085: The effect of azisartan in combination with homocysteine descent therapy on left ventricular structure and function in patients with H-type hypertension and atrial fibrillation: a randomized, open-label, parallel controlled trial |
|
|
| Not yet recruiting | N/A | 196 | | Azilsartan 40 mg QD PO ;Candesartan 8 mg QD PO | The First Affiliated Hospital of Zhejiang University School of Medicine; The First Affiliated Hospital of Zhejiang University School of Medicine, Heng Xin Hypertension/Heart-Kidney Protection Medical Research Fund | H type Hypertension with atrial fibrillation | | | | |
ChiCTR2300071978: Duration of azilsartan for the treatment of nonscoop essential hypertension and long-term prognosis: a randomized controlled study |
|
|
| Not yet recruiting | N/A | 640 | | patients were instructed to take azilsartan in the morning (6:00-10:00), and the medication was adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure ;patients were instructed to take olmesartan cilexetil in the morning (6:00-10:00), and the medication was adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure ;patients are instructed to take azilsartan before bedtime (20:00-0:00), and the medication is adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure ;patients are instructed to take olmesartan cilexetil before bedtime (20:00-0:00), and the medication is adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure | Renmin Hospital of Wuhan University; Renmin Hospital of Wuhan University, Huaxia Cardiovascular Health Research Institute of Suzhou Industrial Park | hypertension | | | | |